These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8739813)
21. Large artery compliance in essential hypertension. Effects of calcium antagonism and beta-blocking. De Cesaris R; Ranieri G; Filitti V; Andriani A Am J Hypertens; 1992 Sep; 5(9):624-8. PubMed ID: 1358118 [TBL] [Abstract][Full Text] [Related]
22. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related]
23. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854 [TBL] [Abstract][Full Text] [Related]
24. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine? El-Ghoroury H; Sudekum DM; Hecht JP J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067 [TBL] [Abstract][Full Text] [Related]
26. Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Nakagawa TA; Sartori SC; Morris A; Schneider DS Pediatr Cardiol; 2004; 25(1):26-30. PubMed ID: 14534761 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of nicardipine in 29,104 patients with hypertension. Dubois C; Blanchard D Clin Ther; 1989; 11(4):452-60. PubMed ID: 2673515 [TBL] [Abstract][Full Text] [Related]
28. Nicardipine and propranolol in the treatment of essential hypertension. Lessem JN; Barone EJ; Berl T; Detwiler J; Lewin AT; Lubash GD; Margolis R; McGowan RL; Ram CV; Vlachakis N Am J Hypertens; 1989 Mar; 2(3 Pt 1):146-53. PubMed ID: 2645914 [TBL] [Abstract][Full Text] [Related]
29. [Antihypertensive effect and tolerability of slow-release nicardipine]. Fogari R; Poletti L; Tettamanti F; Malamani G; Borgnino C Cardiologia; 1989 Feb; 34(2):161-5. PubMed ID: 2660993 [TBL] [Abstract][Full Text] [Related]
30. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine. Bellet M; Loria Y; Lallemand A J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302 [TBL] [Abstract][Full Text] [Related]
32. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group. Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973 [TBL] [Abstract][Full Text] [Related]
33. The effect of slow-release nicardipine on ambulatory and clinic blood pressure in mild hypertension. Cox JP; Ryan J; O'Brien E; O'Malley K Br J Clin Pharmacol; 1989 Jul; 28(1):79-82. PubMed ID: 2673316 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681 [TBL] [Abstract][Full Text] [Related]
35. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study. Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823 [TBL] [Abstract][Full Text] [Related]
36. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension]. Benvenuti C; Guerini Rocco C; Trezzi P Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269 [TBL] [Abstract][Full Text] [Related]
37. Clinical trial of nicardipine in treatment of mild to moderate hypertension. Yajnik VH; Vatsaraj DJ; Acharya HK; Yajnik NV J Assoc Physicians India; 1995 Jun; 43(6):401-3. PubMed ID: 8906946 [No Abstract] [Full Text] [Related]
38. Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report. Mahmud A; Feely J Hypertension; 2007 Feb; 49(2):272-5. PubMed ID: 17178976 [TBL] [Abstract][Full Text] [Related]
39. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. Bobrie G; Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847 [TBL] [Abstract][Full Text] [Related]
40. Intravenous nicardipine for treatment of severe hypertension in children. Flynn JT; Mottes TA; Brophy PD; Kershaw DB; Smoyer WE; Bunchman TE J Pediatr; 2001 Jul; 139(1):38-43. PubMed ID: 11445792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]